Literature DB >> 6651349

Asbestos-related mesothelioma: epidemiological evidence for asbestos as a promoter.

K Browne.   

Abstract

A series of 144 cases of mesothelioma among asbestos workers indicated important divergences from the epidemiological pattern shown to exist for asbestos-related lung cancer. Consideration of exposure duration and intensity and the latent period between first exposure and death suggests that asbestos does not act as a complete carcinogen, but as a promoter. A threshold seems probable for both duration and intensity of exposure in the induction of mesothelioma. This threshold may, in part, be related to the passage of fibers from the lungs to the pleura or peritoneum, and would, in any case, be masked in lung cancer by the retention of asbestos in the lungs. Reported cases of mesothelioma in immediate family members indicate the existence of an additional factor in mesothelioma induction, acting earlier in life than the first asbestos exposure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651349     DOI: 10.1080/00039896.1983.10544004

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  7 in total

Review 1.  Malignant mesothelioma.

Authors:  R Rudd
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

Review 2.  Assessment of mineral fibres from human lung tissue.

Authors:  J M Davis; B Gylseth; A Morgan
Journal:  Thorax       Date:  1986-03       Impact factor: 9.139

3.  Mechanisms of asbestos carcinogenesis and toxicity: the amphibole hypothesis revisited.

Authors:  B T Mossman
Journal:  Br J Ind Med       Date:  1993-08

4.  Mesothelioma due to domestic exposure to asbestos.

Authors:  K Browne; T Goffe
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-14

Review 5.  Mesothelioma: cases associated with non-occupational and low dose exposures.

Authors:  G Hillerdal
Journal:  Occup Environ Med       Date:  1999-08       Impact factor: 4.402

6.  Cancer morbidity in Swedish shipyard workers 1978-1983.

Authors:  A Sandén; B Järvholm
Journal:  Int Arch Occup Environ Health       Date:  1987       Impact factor: 3.015

7.  Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenografts.

Authors:  Sherrill L Macura; Jeremy L Steinbacher; Maximilian B Macpherson; Melissa J Lathrop; Mutlay Sayan; Jedd M Hillegass; Stacie L Beuschel; Timothy N Perkins; Page C Spiess; Albert van der Vliet; Kelly J Butnor; Arti Shukla; Marilyn Wadsworth; Christopher C Landry; Brooke T Mossman
Journal:  BMC Cancer       Date:  2013-09-11       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.